Literature DB >> 18715927

Hepatitis C virus-specific T-cell gamma interferon and proliferative responses are more common in perihepatic lymph nodes than in peripheral blood or liver.

Dilip Moonka1, Kimberly A Milkovich, Benigno Rodriguez, Marwan Abouljoud, Michael M Lederman, Donald D Anthony.   

Abstract

The activation state, differentiation state, and functions of liver lymphocytes and perihepatic lymph nodes during chronic hepatitis C virus (HCV) infection are not well understood. Here, we performed phenotypic and functional analyses of freshly prepared lymphocytes isolated from the livers, perihepatic lymph nodes, and peripheral blood compartments of chronic HCV-infected and disease control subjects with end-stage liver disease undergoing liver transplantation. We measured lymphocyte subset frequency and memory T-cell gamma interferon (IFN-gamma) and proliferative responses to HCV peptide and control viral antigens in direct ex vivo assays. We found higher frequencies of CD4 cells in the lymph node compartment than in the other compartments for both HCV-infected and disease control subjects. Lymph node CD4 and CD8 cells less commonly expressed the terminal differentiation marker CD57, a finding consistent with an earlier differentiation state. In HCV-infected subjects, HCV-specific IFN-gamma-producing and proliferative responses were commonly observed in the lymph node fraction, while they were uncommonly observed in the peripheral blood or liver fractions. In contrast, control viral CD4 protein antigen and CD8 peptide antigen-specific IFN-gamma responses were commonly observed in the periphery and uncommonly observed in the lymph nodes of these same subjects. These findings are consistent with a selective defect in HCV-specific T-cell effector function or distribution in patients with advanced chronic HCV infection. The high frequency of HCV-reactive T cells in perihepatic lymph nodes indicates that a failure to generate or sustain T-lymphocyte HCV reactivity is not responsible for the paucity of functional cells even in end-stage liver disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18715927      PMCID: PMC2583684          DOI: 10.1128/JVI.01130-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.

Authors:  G Missale; R Bertoni; V Lamonaca; A Valli; M Massari; C Mori; M G Rumi; M Houghton; F Fiaccadori; C Ferrari
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C.

Authors:  D R Nelson; C G Marousis; G L Davis; C M Rice; J Wong; M Houghton; J Y Lau
Journal:  J Immunol       Date:  1997-02-01       Impact factor: 5.422

3.  Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes.

Authors:  S Norris; C Collins; D G Doherty; F Smith; G McEntee; O Traynor; N Nolan; J Hegarty; C O'Farrelly
Journal:  J Hepatol       Date:  1998-01       Impact factor: 25.083

Review 4.  The role of immune responses in the pathogenesis of hepatitis C virus infection.

Authors:  M J Koziel
Journal:  J Viral Hepat       Date:  1997       Impact factor: 3.728

Review 5.  Cell-mediated immunity and the outcome of hepatitis C virus infection.

Authors:  Naglaa H Shoukry; Andrew G Cawthon; Christopher M Walker
Journal:  Annu Rev Microbiol       Date:  2004       Impact factor: 15.500

6.  Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C.

Authors:  A L Erickson; M Houghton; Q L Choo; A J Weiner; R Ralston; E Muchmore; C M Walker
Journal:  J Immunol       Date:  1993-10-15       Impact factor: 5.422

7.  The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo.

Authors:  L Huang; G Soldevila; M Leeker; R Flavell; I N Crispe
Journal:  Immunity       Date:  1994-12       Impact factor: 31.745

8.  Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV.

Authors:  Camilla S Graham; Michael Curry; Qi He; Nezam Afdhal; David Nunes; Catherine Fleming; Robert Horsburgh; Donald Craven; Kenneth E Sherman; Margaret James Koziel
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

9.  High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection.

Authors:  Georg M Lauer; Eleanor Barnes; Michaela Lucas; Joerg Timm; Kei Ouchi; Arthur Y Kim; Cheryl L Day; Gregory K Robbins; Deborah R Casson; Markus Reiser; Geoffrey Dusheiko; Todd M Allen; Raymond T Chung; Bruce D Walker; Paul Klenerman
Journal:  Gastroenterology       Date:  2004-09       Impact factor: 22.682

10.  Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease.

Authors:  Anne M Wertheimer; Antony Bakke; Hugo R Rosen
Journal:  Hepatology       Date:  2004-08       Impact factor: 17.425

View more
  3 in total

Review 1.  Adaptive immunity to the hepatitis C virus.

Authors:  Christopher M Walker
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

Review 2.  A spatial view of the CD8+ T-cell response: the case of HCV.

Authors:  Vito Racanelli; Patrizia Leone; Arash Grakoui
Journal:  Rev Med Virol       Date:  2011-07-05       Impact factor: 6.989

3.  Perihepatic lymph node enlargement is a negative predictor of liver cancer development in chronic hepatitis C patients.

Authors:  Hiromi Hikita; Hayato Nakagawa; Ryosuke Tateishi; Ryota Masuzaki; Kenichiro Enooku; Haruhiko Yoshida; Masao Omata; Yoko Soroida; Mamiko Sato; Hiroaki Gotoh; Atsushi Suzuki; Tomomi Iwai; Hiromitsu Yokota; Kazuhiko Koike; Yutaka Yatomi; Hitoshi Ikeda
Journal:  J Gastroenterol       Date:  2012-07-12       Impact factor: 7.527

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.